Biontech Se Stock In The News
| BNTX Stock | USD 88.09 0.40 0.45% |
The overall news coverage of BioNTech SE from major news outlets shows bullish sentiment on 19 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of BioNTech's news coverage and content from conventional and social sources shows investors' bearish mood towards BioNTech SE. The specific impact of BioNTech news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of BioNTech's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using BioNTech headlines in addition to utilizing other, more conventional financial analysis modules. Check out BioNTech Backtesting and BioNTech Hype Analysis.
BioNTech |
BioNTech Today Top News and Investor Outlook
BioNTech SE Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide BioNTech and other traded companies coverage. We help investors stay connected with BioNTech headlines for the 25th of April to make an informed investment decision based on correlating the impacts of news items on BioNTech Stock performance. Please note that trading solely based on the BioNTech SE hype is not for everyone as timely availability and quick action are needed to avoid losses.BioNTech stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the BioNTech earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about BioNTech that are available to investors today. That information is available publicly through BioNTech media outlets and privately through word of mouth or via BioNTech internal channels. However, regardless of the origin, that massive amount of BioNTech data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BioNTech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioNTech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioNTech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioNTech alpha.
BioNTech Largest EPS Surprises
Earnings surprises can significantly impact BioNTech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-05-12 | 2020-03-31 | -0.27 | -0.24 | 0.03 | 11 | ||
2019-11-14 | 2019-09-30 | -0.16 | -0.13 | 0.03 | 18 | ||
2020-03-31 | 2019-12-31 | -0.17 | -0.26 | -0.09 | 52 | ||
2023-08-07 | 2023-06-30 | -0.96 | -0.79 | 0.17 | 17 | ||
2020-08-11 | 2020-06-30 | -0.06 | -0.38 | -0.32 | 533 | ||
2020-11-10 | 2020-09-30 | -0.37 | -0.88 | -0.51 | 137 |
BioNTech Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to BioNTech SE Stock. Current markets are slightly bullish. About 53% of major world exchanges and indexes are currently up. See today's market update for more information.
23rd of April 2024
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Sho... at benzinga.com
22nd of April 2024
25 Richest Billionaires in Healthcare Industry at finance.yahoo.com
11th of April 2024
Will Pfizers New Drugs Provide a Boost to 2024 Sales at zacks.com
9th of April 2024
Election Year Encore Can 2020s Top 7 Stock Winners Repeat Their Performance in 2024 at investorplace.com
4th of April 2024
Fifth Third Bancorp Has 1.76 Million Stake in BioNTech SE - Defense World at news.google.com
28th of March 2024
Petri Dish NIH sends BioNTech notice of default Intellia ends Regeneron deal at bizjournals.com
26th of March 2024
3 Biotech Stocks to Buy for the Next Bull Run March 2024 at investorplace.com
21st of March 2024
BioNTech Full Year 2023 Earnings Misses Expectations at simplywall.st
20th of March 2024
BioNTech beruft Annemarie Hanekamp als Chief Commercial Officer in den Vorstand at globenewswire.com
12th of March 2024
BioNTech SE Sued for Securities Law Violations Investors Should Contact Levi Korsinsky for... at accesswire.com
8th of March 2024
Levi Korsinsky Announces the Filing of a Securities Class Action on Behalf of BioNTech SE ... at accesswire.com
5th of March 2024
Heres Why BioNTech SE Declined 12.2 percent in Q4 at finance.yahoo.com
BioNTech Investors Sentiment
The influence of BioNTech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in BioNTech. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to BioNTech's public news can be used to forecast risks associated with an investment in BioNTech. The trend in average sentiment can be used to explain how an investor holding BioNTech can time the market purely based on public headlines and social activities around BioNTech SE. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
BioNTech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BioNTech's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average BioNTech's news discussions. The higher the estimated score, the more favorable is the investor's outlook on BioNTech.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioNTech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioNTech's short interest history, or implied volatility extrapolated from BioNTech options trading.
Check out BioNTech Backtesting and BioNTech Hype Analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for BioNTech Stock analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is BioNTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share 4.08 | Revenue Per Share 15.873 | Quarterly Revenue Growth (0.65) | Return On Assets 0.0262 |
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.